SEC Form 4

FORM 4		UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940	OMB APPROVAL OMB Number: 3235-0287 Estimated average burden hours per response: 0.5
	Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person* Sandor Capital Master Fund, L.P. (Last) (First) (Middle) 2828 ROUTH STREET SUITE 500 (Street) DALLAS TX 75201 (City) (State) (Zip)	2. Issuer Name and Ticker or Trading Symbol NORTHSIGHT CAPITAL, INC. [ NCAP ]	5. Relationship of Reporting Person(s) to Issuer (Check all applicable) Director X 10% Owner Officer (give title below) Other (specify below)
	3. Date of Earliest Transaction (Month/Day/Year) 10/16/2017
	4. If Amendment, Date of Original Filed (Month/Day/Year)	6. Individual or Joint/Group Filing (Check Applicable Line) Form filed by One Reporting Person X Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock								27,250,020	D(1)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Common Stock Puchase Warrant	$0.05	10/16/2017		H(2)		2,000,000		(3)	12/10/2017	Common Stock	2,000,000	$0	0	D
Common Stock Purchase Warrant	$0.25	10/16/2017		H(4)		714,285		10/27/2015	10/27/2017	Common Stock	714,285	$0	0	D
Common Stock Purchase Warrant	$0.1	10/16/2017		J(5)		1,130,285		10/16/2017	10/16/2020	Common Stock	1,130,285	$0	1,130,285	D(1)
Common Stock Purchase Warrant	$0.05	10/16/2017		J(6)		9,000,000		10/16/2017	10/16/2020	Common Stock	9,000,000	$0	9,000,000	D(1)

1. Name and Address of Reporting Person* Sandor Capital Master Fund, L.P. (Last) (First) (Middle) 2828 ROUTH STREET SUITE 500 (Street) DALLAS TX 75201 (City) (State) (Zip) Relationship of Reporting Person(s) to Issuer Director X 10% Owner Officer (give title below) Other (specify below)

1. Name and Address of Reporting Person* Lemak John S (Last) (First) (Middle) 4410 BORDEAUX AVENUE (Street) DALLAS TX 75205 (City) (State) (Zip) Relationship of Reporting Person(s) to Issuer Director 10% Owner Officer (give title below) X Other (specify below) General Partner

Explanation of Responses:

1. John Lemak, who is jointly filing this Form 4, beneficially owns indirectly his proportionate interest in the securities beneficially owned by the designated filing person, Sandor Capital Master Fund, LLP, which is controlled by Mr. Lemak.

2. These 2 million warrants were cancelled and warrants for the same number of shares at the same exercise price were issued to replace them. Said new warrants are included in the 9 million warrants acquired on the same date and reported herein. See Note 6 below.

3. This warrant (which has been cancelled) was exercisable upon 75 days written notice to the issuer.

4. These 714,285 warrants were cancelled and warrants for the same number of shares at an exercise price of $.10 were issued to replace them. Said new warrants are included in the 1,130,285 warrants acquired on the same date and reported herein. See Note 5 below.

5. 714,285 of these warrants were issued to replace a like number of warrants having an exercise price of $.25 that were cancelled on the same date and reported herein. The issuer issued the remaining 416,000 warrants in recognition of the reporting person having previously provided advances to the company.

6. 2 million of these 9 million warrants were issued to replace a like number of warrants at the same exercise price that were cancelled on the same date and reported herein. The issuer issued the remaining 7 million warrants in recognition of the reporting person having previously provided advances to the company.

	/s/ John Lemak, individually	10/18/2017
	/s/ John Lemak, General Partner	10/18/2017
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.